Arax Advisory Partners’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.3K | Sell |
1,870
-103
| -5% | -$1.83K | ﹤0.01% | 1430 |
|
|
2025
Q1 | $35.2K | Buy |
1,973
+1,040
| +111% | +$18.5K | ﹤0.01% | 1083 |
|
|
2024
Q4 | $27.8K | Sell |
933
-275
| -23% | -$8.2K | ﹤0.01% | 1089 |
|
|
2024
Q3 | $18.9K | Buy |
1,208
+724
| +150% | +$11.3K | ﹤0.01% | 1110 |
|
|
2024
Q2 | $8.29K | Buy |
+484
| New | +$8.29K | ﹤0.01% | 1362 |
|